Current Report Filing (8-k)
10 2월 2021 - 6:16AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): February 3, 2021
OMNIA
WELLNESS INC.
(Exact
Name of Registrant as Specified in Charter)
Nevada
|
|
333-211986
|
|
98-1291924
|
(State
or Other Jurisdiction
of
Incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
999
18th Street
Suite
3000
Denver,
Colorado 80202
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: (303) 325-3738
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
Registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [X]
|
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
1.01
|
Entry
Into A Material Agreement.
|
On
February 3, 2021, Omnia Wellness Inc. (the “Company”) entered into an Extension to Promissory Note (the “Extension”),
effective as of January 31, 2021, with an existing lender (the “Lender”), which extended the maturity date of the
loan with the Lender in the principal amount of $500,000 (the “Existing Loan”) to January 31, 2022. The Extension
also provided that the Lender can demand a one-time early repayment of the Existing Loan at any time prior to the Maturity Date.
As
consideration for the Extension, the Company agreed to issue to the Lender 20,000 shares of its common stock (the “Consideration
Shares”).
The
foregoing is a brief description of the terms of the Extension and is qualified in its entirety by reference to the full text
of the Extension, the form of which is included as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein
by reference.
The
information set forth in Item 2.03 is incorporated by reference into this Item 1.01.
Item
2.03
|
Creation
of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
|
On
February 8, 2021, the Company borrowed $140,000 (the “Loan”) from a new investor (the “Investor”) pursuant
to a 20% Note due on May 31st, 2021, with an issue date of February 2, 2021 (the “Note”).
The
Company intends to use the net proceeds from the Loan for the Company’s working capital and general corporate purposes.
The
Note contains customary events of default, which, if uncured, entitle the Investor to accelerate the due date of the unpaid principal
amount of the Note, and the outstanding balance shall increase to 120% of the outstanding balance immediately prior to the event
of default.
Nickolay
Kukekov, a director of the Company, has agreed to personally guarantee the payments of all amounts under the Note.
The
foregoing is a brief description of the terms of the Note and is qualified in its entirety by reference to the full text of the
Note, the form of which is included as Exhibit 10.2 to this Current Report on Form 8-K, which is incorporated herein by reference.
Item
3.02
|
Unregistered
Sales of Equity Securities
|
On
February 9, 2021, the Company issued the Consideration Shares. Additionally, the Company issued on February 9, 2021 an additional
177,650 shares of common stock to an existing investor upon the conversion of such investor’s loan to the Company of approximately
$320,000 in principal plus accrued interest. All of such shares were issued in reliance on the exemption from registration provided
by Section 4(a)(2) of the Securities Act of 1933, as amended, as no general solicitation was used in the offer and sale of such
securities.
Item
9.01
|
Financial
Statements and Exhibits.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
Date:
February 9, 2021
|
OMNIA
WELLNESS INC.
|
|
|
|
|
By:
|
/s/
Steve Howe
|
|
Name:
|
Steve
Howe
|
|
Title:
|
Executive
Chairman
|
Omnia Wellness (CE) (USOTC:OMWS)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Omnia Wellness (CE) (USOTC:OMWS)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Omnia Wellness Inc (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Omnia Wellness Inc. News Articles